Nova Eye USA Sales Growth Opportunity slide image

Nova Eye USA Sales Growth Opportunity

ع ng Glaucoma Product Portfolio and Disease State Portfolio of glaucoma technologies addressing different stages of the disease PROGRAM STATUS STAGE OF GLAUCOMA MILD GLAUCOMA MODERATE GLAUCOMA SEVERE GLAUCOMA COMPLEX GLAUCOMA COMMERCIAL iTrack™ ADVANCE Canaloplasty device injector deployed by comprehensive ophthalmologist in conjunction with cataract surgery. iTrack™ ADVANCE Canaloplasty device injector deployed by glaucoma specialist as standalone procedure - restores trabecular flow. iTrack™ Canaloplasty manually deployed by glaucoma specialist with scleral surgery and/or suture- restores trabecular flow. Molteno3Ⓡ Glaucoma drainage device deployed by glaucoma specialist - drainage device bypassing trabecular flow. Product development opportunities Severe and complex glaucoma is an underserved segment. Product range to cater to the preferences of eye surgeons treating broader range of patients with expansion of reimbursement codes. nova-eye.com | 16
View entire presentation